9.60

2.24% 0.21

Leonabio Inc (LONA)

Overview News Price History Discussions Forecast

Leonabio Inc stock is traded at $9.60, with a volume of 39,048. It is up +2.24% in the last 24 hours and up +13.88% over the past month. LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Previous Close:

$9.39

Open:

$9.12

24h Volume:

39,048

Relative Volume:

1.18

Market Cap:

$90.18M

Revenue:

Net Income/Loss:

$-129.41M

P/E Ratio:

-0.3985

EPS:

-24.0922

Net Cash Flow:

$-51.97M

1W Performance:

+8.23%

1M Performance:

+13.88%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$9.10

$9.6985

1-Week Range:

$8.03

$9.6985

52-Week Range:

$4.21

$14.21

Leonabio Inc Stock (LONA) Company Profile

Name

Leonabio Inc

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

(425) 620-8501

Address

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

LONA's Discussions on Twitter

Compare LONA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LONA Leonabio Inc	9.60	90.18M	0	-129.41M	-51.97M	-24.09
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Leonabio Inc Stock (LONA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Initiated	Cantor Fitzgerald	Overweight
Feb-19-26	Upgrade	Mizuho	Neutral → Outperform
Sep-19-24	Downgrade	Mizuho	Outperform → Neutral
Sep-04-24	Downgrade	BTIG Research	Buy → Neutral
Sep-04-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-04-24	Downgrade	Rodman & Renshaw	Buy → Neutral
Aug-19-24	Initiated	Rodman & Renshaw	Buy
Oct-17-22	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Jul-07-22	Initiated	Mizuho	Buy
Jun-23-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-23-22	Downgrade	Jefferies	Buy → Hold
Jun-23-22	Downgrade	Stifel	Buy → Hold
May-10-22	Initiated	BTIG Research	Buy
Apr-21-22	Initiated	Berenberg	Buy
Dec-15-21	Initiated	Goldman	Neutral
Oct-13-20	Initiated	Goldman	Buy
Oct-13-20	Initiated	JMP Securities	Mkt Outperform
Oct-13-20	Initiated	Jefferies	Buy
Oct-13-20	Initiated	Stifel	Buy

View All

Leonabio Inc Stock (LONA) Latest News

Jul 10, 2026

Form 4 LeonaBio Inc For: 10 July By Investing.com - Investing.com Nigeria

Jul 10, 2026

LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role - Stock Titan

Jul 10, 2026

Jul 09, 2026

Form 4 LeonaBio Inc For: 9 July By Investing.com - Investing.com Nigeria

Jul 09, 2026

LeonaBio (LONA) director entities receive 28,000 stock options grant - Stock Titan

Jul 09, 2026

Jul 05, 2026

LeonaBio (LONA) Gains 5.85% as Biotech Stock Approaches Key ResistanceIPO Entry Watch - dars.gov.et

Jul 05, 2026

LONA Q1 2026 Earnings: EPS Surprise of 32% Powers 5.85% Share RallyEPS Estimate Trend - dars.gov.et

Jul 05, 2026

Jun 29, 2026